Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


Making genetic tests reduces the number of unnecessary treatments

The Penn Medicine researchers analyzed the impact of genetic testing for the CYP2C19 genotype. According to the study, immediate access to test results reduces the need for unnecessary drug treatments.

One of the most common treatments against arterial blockages is percutaneous coronary intervention. This is a non-invasive procedure, after which doctors prescribe aspirin and antiplatelet drugs. In this way the formation of plaques inside the arteries is avoided. Some patients respond negatively to this type of drug treatment.

According to some studies, the ineffective or negative response is linked to a mutation of the CYP2C19 gene. The person presenting the mutation should receive a different pharmacological treatment. The researchers then entered the genetic mutation test in the clinical protocol of 249 patients. The idea was to provide their doctors with immediate data on the presence or absence of this anomaly.

The study involved 504 patients: 249 performed the test; 255 who did not do it. Patients who did the genetic test received the results in one day. Their doctors received it even 90 minutes later. The latter also received the advice of a geneticist and some treatment recommendations. Once all the data was analyzed, the doctors made their prescriptions.

In 71% of cases, doctors followed the recommendations received from the geneticist. Indeed, some of them also analyzed different factors, which the test could not take into consideration. In many cases, the results have revealed the need to prescribe different treatments from the standard one. All of this resulted in fewer heart attacks, strokes and deaths related to cardiovascular factors.

Source: eurekalert.org

Empathy is about the genes

The ability to identify with those in front of us is a quality written in our genes. This is shown by a team of scientists from four major international institutions. The researchers who participated in the study come from the University of Cambridge, the Pasteur Institute, the Diderot University and the CNRS.

In 2002 a Cambridge team carried out a test to calculate how empathetic a person was. The questions measure the empathy quotient (EQ) of the person by evaluating cognitive and affective empathy. The first is the ability to recognize the feelings and thoughts of others; the second is the ability to respond with an appropriate emotion.

Thanks to the test it was discovered that the level of empathy changes from person to person. Furthermore, women are on average more empathetic than men. The researchers then decided to study the biological causes of these differences. The international study revealed that empathy is the result of both environmental factors and genetic factors.

The researchers tested the empathy quotient for 46,000 people. Then they also took a sample of saliva from each of them in order to analyze their DNA. Comparing the two results, it emerged that the level of empathy depends on genetic factors at least for a tenth. These minimal genetic variations could be the root for behavioral disorders.

Although women are more empathetic on average, there does not seem to be any significant genetic difference. According to the researchers, the merit could be hormonal levels, very different between the two genera.

Source: panorama.it

Make 350 rare disease diagnoses thanks to "Vite Coraggiose"

The campaign Vite Coraggiose of the Bambino Gesù Foundation is aimed at those who suffer from genetic diseases without a diagnosis. The scientific director Bruno Dallapiccola announced the first results of the initiative: 350 diagnoses, about 50% of patients entered the program.

Much of the credit goes to the multidisciplinary clinical approach and to the use of genetic sequencing technologies. The many tools at the disposal of the Infant Jesus also contributed. The hospital has in fact treated about 10,000 patients suffering from rare diseases, especially pediatric diseases. It also houses the Italian headquarters of Orphanet, to date the database for rare diseases par excellence. All these elements have managed to give an answer to those who have been waiting for a long-time diagnosis.

The results obtained in 2 years with Vite Coraggiose are only the last in terms of time. In recent years, the Bambino Gesù researchers have identified 17 new genes related to diseases. In addition, they identified 16 rare diseases and opened a clinic dedicated to those who are still without a diagnosis.

The clinic dedicated to patients without a diagnosis is aimed at patients throughout Italy. Families can interact with doctors for a first remote diagnostic opinion. Any movement will come later and only if necessary. A considerable help for those who have relatives suffering from disabling diseases and that prevent them from moving. If clinical analyzes do not provide an answer, we proceed with genomic analyzes.

Up to now the approach of Vite Coraggiose has allowed to obtain a diagnosis in about 50% of cases. Having an answer is a big step forward from both a psychological and a practical point of view. It allows you to get to know the disease better and to develop increasingly targeted research programs.

Source: osservatoriomalattierare.it

Sandhoff's disease: causes and symptoms

Sandhoff's disease is a genetic disease that causes the progressive destruction of brain and spinal cord cells. The most common and severe form appears in early childhood, between 3 and 6 months of age. Other less severe and much more rare forms occur during adolescence and adulthood.

The cause of Sandhoff is a mutation of the HEXB gene, which causes a deficit of the enzymes exosaminidase A and exosaminidase B. The two enzymes should be inside the lysosomes, the structures that deal with the disposal of toxic substances. Their malfunction then leads to a progressive accumulation of gangliosides in the brain, causing the death of neurons.

The disease causes the degeneration of brain and spinal cord cells. For this reason, those affected suffer from intellectual and motor disabilities, as well as loss of sight and hearing. Children with Sandhoff's disease have excessively developed livers, bone malformations and respiratory infections.

In order for the disease to manifest itself, both parents must be carriers of the mutated gene. Usually healthy carriers do not show any symptoms, which makes it necessary to resort to appropriate tests. Who has had cases in the family, can undergo a genetic test to check whether or not it is a carrier. In the event of a positive outcome for both partners, in vitro fertilization can be used together with pre-implant genetic tests.

Source: rarediseases.info.nih.gov

Link social

Link social